External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data

• Main Authors: Eleni Karatza (Author), Samit Ganguly (Author), Chi D. Hornik (Author), William J. Muller (Author), Amira Al-Uzri (Author), Laura James (Author), Stephen J. Balevic (Author), Daniel Gonzalez (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Risperidone is approved to treat schizophrenia in adolescents and autistic disorder and bipolar mania in children and adolescents. It is also used off-label in younger children for various psychiatric disorders. Several population pharmacokinetic models of risperidone and 9-OH-risperidone have been...